2004 Annual Meeting | Clinical Epilepsy II

Date Monday 04/26/04

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Gregory K. Bergey, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Upon completion:
Participants should understand the specific considerations important in treating epilepsy in children and the elderly; the importance of prompt treatment of status epilepticus will be appreciated along with the best therapy for these patients; the appropriate use of vagus nerve stimulation; and hear about some of the investigational methods of brain stimulation that may hold promise for future therapy.

The American Board of Psychiatry and Neurology has reviewed Clinical Epilepsy II and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 03:00 PM		Pediatric Epilepsy: Diagnostic and Treatment Considerations Raman Sankar, MD, PhD, FAAN
03:00 PM - 03:45 PM		Epilepsy in the Elderly Ilo Leppik, MD
03:45 PM - 04:00 PM		Questions and Answers
04:00 PM - 04:15 PM		Break
04:15 PM - 05:00 PM		Status Epilepticus Daniel H. Lowenstein, MD
05:00 PM - 05:45 PM		Brain Stimulation in the Treatment of Epilepsy Brian Litt, MD
05:45 PM - 06:00 PM		Discussion

Faculty Disclosures
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Ilo Leppik, MD	Dr. Leppik has nothing to disclose.
Daniel H. Lowenstein, MD	Dr. Lowenstein has received research support from NIH.
Raman Sankar, MD, PhD, FAAN	Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sankar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BioMarin. Dr. Sankar has received publishing royalties from a publication relating to health care. Dr. Sankar has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NINDS, NIH.
Brian Litt, MD	Dr. Litt has received personal compensation in the range of $0-$499 for serving as a Consultant for Beacon Neurosystems. Dr. Litt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG. Dr. Litt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Litt has stock in Orph AI. Dr. Litt has stock in Hyperfine. Dr. Litt has stock in Detect. Dr. Litt has stock in Butterfly. Dr. Litt has stock in Identifeye. Dr. Litt has stock in Protein Evolution. The institution of Dr. Litt has received research support from Mirowski Foundation. The institution of Dr. Litt has received research support from Jonathan and Bonnie Rothberg. The institution of Dr. Litt has received research support from Neil and Barbara Smit. Dr. Litt has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file

��ɫ��

��ɫ��